Suggestions
Dylan Clark
Associate Director, QC Systems Compliance at Taysha Gene Therapies
Professional Background
Dylan Clark is a self-motivated professional with over 15 years of extensive experience in FDA-regulated environments. His career has been marked by a deep understanding of project management and business analysis with a focus on systems lifecycle management. In his current role as Associate Director of QC Systems Compliance at Taysha Gene Therapies, Dylan leads initiatives that ensure product quality and regulatory compliance within the organization. Previously, he held the position of Associate Director of Operations Technology at Kriya Therapeutics, where he leveraged his broad expertise to enhance operational efficiency and streamline processes.
Dylan's robust career includes vital roles at several prominent organizations in the biotechnology and pharmaceutical industries. As a former Senior Manager at bluebird bio, he managed quality control electronic systems and Laboratory Information Management Systems (LIMS). His experience as a Senior Manager of Software & Data Management Services at Sequence Inc. highlighted his ability to blend technology with regulatory expectations expertly.
Dylan has also made significant contributions as Midwest Regional Relationship Manager at Sequence Inc., driving client relationships and ensuring satisfaction through excellent service. Prior to these roles, he demonstrated his technical acumen as a Senior Validation Engineer at LabWare and an IT Consultant at Sequence Inc., where he emphasized the importance of computer system validation and data integrity. Throughout his career, Dylan has played a crucial role in ensuring the quality of processes and products, making him a respected figure in the FDA-regulated landscape.
Education and Achievements
Dylan Clark's academic background sets a strong foundation for his career in the highly regulated field of biotechnology and quality assurance. He earned his Bachelor of Science in Biological Sciences from Butler University, where he developed a comprehensive understanding of biological principles and laboratory practices. Pursuing further education, Dylan obtained a Master of Science in Information Systems from DePaul University. This unique combination of biological sciences and information systems gives him a distinctive edge in managing complex projects that intersect technology and life sciences effectively.
His commitment to ongoing professional development is evident throughout his career, where he has continuously sought opportunities to enhance his skills in project management, software data management, and quality assurance. Dylan remains current with industry trends, ensuring that his knowledge and practices align with the evolving landscape of FDA regulations and technological advancements.
Notable Projects and Contributions
Dylan's contributions extend beyond mere compliance; he embodies the integration of technology into scientific research and regulation. At Taysha Gene Therapies, he spearheaded the implementation of a validation framework that reduced the time to market for new therapies while maintaining rigorous adherence to quality standards. His innovative approach has significantly increased the organization's capacity to deliver safe and effective treatments to patients in need.
While working at bluebird bio, he played an instrumental role in the transformation of their quality control systems, adopting advanced LIMS technologies that dramatically improved data accuracy and operational efficiency. His leadership during this project not only enhanced the organization's data integrity practices but also established new benchmarks for future initiatives in quality assurance.
Dylan’s earlier work as a Bioanalytical Chemist at Eli Lilly and Company and his experiences at PepsiCo as a QA Microbiologist exemplified his solid analytical skills and attention to detail. These roles cultivated a strong sense of accountability in quality assurance processes, emphasizing the need for reliable data and thorough validation.
His strategic mindset and ability to adapt to rapidly evolving environments have made him an invaluable asset in every role he has undertaken. Throughout his career, Dylan Clark has become synonymous with quality, reliability, and innovation—qualities that set him apart as a leader in the biotechnology and pharmaceutical sectors.